Eric B Arnold, MD
Psychiatry · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 1 carrier
- Office
- 1
- Since medical school
- 16 years
- University of Texas Southwestern Medical School at Dallas, 2010
Offices
1 location · Bay Psychiatric Associates · 60 clinicians in this group
Hospitals listed: Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp. That is not proof they admit you there this week.
Plans that list them
11 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Arnold’s office at (510) 204-4635 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A117757 · Current
Licensed to practise in California · since 2011 · expires 2027-06-30 · University of Texas Southwestern Medical School at Dallas.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Psychiatry
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$252,781
Medicare paid this office $252,781 for 144 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 94 | $100,715 | $104 |
| Psychotherapy with evaluation and management visit, 45 minutes | 58 | $41,512 | $70 |
| Psychotherapy with evaluation and management visit, 30 minutes | 87 | $35,550 | $56 |
| Therapy using electrical currents | 45 | $27,391 | $90 |
| Return visit (30+ min) | 28 | $24,551 | $86 |
See all 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 94 | $100,715 | $104 |
| Psychotherapy with evaluation and management visit, 45 minutes | 58 | $41,512 | $70 |
| Psychotherapy with evaluation and management visit, 30 minutes | 87 | $35,550 | $56 |
| Therapy using electrical currents | 45 | $27,391 | $90 |
| Return visit (30+ min) | 28 | $24,551 | $86 |
| Short return visit (20+ min) | 35 | $12,078 | $58 |
| Psychiatric diagnostic evaluation with medical services | 64 | $10,425 | $135 |
Who their Medicare patients are
144 Original Medicare patients in 2024. Average age 62 · Under 65 44% · Women 56% · Also on Medicaid 67% · Health risk score 1.46. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 75% · High blood pressure 65% · Diabetes 25% · COPD 17% · Chronic kidney disease 16% · Dementia 15% · Coronary heart disease 10% · Cancer 10% · Stroke 9% · Heart failure 8% · Atrial fibrillation 8%.
The office billed $908,810, Medicare allowed $319,947 and paid $252,781; for 3,081 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 144 | 3,081 | 62 | 1.46 | $908,810 | $252,781 |
| 2023 | 115 | 2,338 | 61 | 1.66 | $716,460 | $194,482 |
| 2022 | 122 | 2,086 | 63 | 1.49 | $622,330 | $163,372 |
| 2021 | 114 | 1,811 | 60 | 1.42 | $545,390 | $147,932 |
| 2020 | 129 | 2,095 | 60 | 1.46 | $630,895 | $171,680 |
| 2019 | 122 | 1,671 | 57 | 1.60 | $501,215 | $132,877 |
| 2018 | 98 | 1,076 | 58 | 1.42 | $304,840 | $82,100 |
| 2017 | 97 | 1,076 | 60 | 1.23 | $272,410 | $77,377 |
| 2016 | 96 | 1,295 | 60 | 1.57 | $288,410 | $89,098 |
| 2015 | 95 | 850 | 60 | 1.37 | $191,275 | $59,043 |
| 2014 | 68 | 622 | 58 | 1.16 | $131,300 | $42,280 |
| 2013 | 36 | 116 | 54 | 1.74 | $23,120 | $6,338 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $78,251 | $104 |
| Psychotherapy with evaluation and management visit, 45 minutes | 52 | $31,106 | $67 |
| Therapy using electrical currents | 50 | $30,352 | $91 |
| Psychotherapy with evaluation and management visit, 30 minutes | 58 | $20,885 | $53 |
| Return visit (30+ min) | 25 | $13,212 | $85 |
| Psychiatric diagnostic evaluation with medical services | 66 | $10,758 | $140 |
| Short return visit (20+ min) | 33 | $9,736 | $59 |
2022: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 85 | $67,796 | $90 |
| Psychotherapy with evaluation and management visit, 45 minutes | 60 | $26,766 | $68 |
| Psychotherapy with evaluation and management visit, 30 minutes | 77 | $26,389 | $55 |
| Therapy using electrical currents | 33 | $18,618 | $89 |
| Return visit (30+ min) | 25 | $11,811 | $84 |
| Psychiatric diagnostic evaluation with medical services | 56 | $9,553 | $143 |
| Short return visit (20+ min) | 13 | $1,654 | $59 |
2021: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $61,399 | $92 |
| Psychotherapy with evaluation and management visit, 45 minutes | 53 | $33,700 | $70 |
| Psychotherapy with evaluation and management visit, 30 minutes | 63 | $16,892 | $56 |
| Therapy using electrical currents | 33 | $13,128 | $91 |
| Return visit (30+ min) | 20 | $11,922 | $89 |
| Psychiatric diagnostic evaluation with medical services | 58 | $10,108 | $144 |
2020: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 87 | $69,410 | $95 |
| Psychotherapy with evaluation and management visit, 45 minutes | 58 | $29,250 | $74 |
| Psychotherapy with evaluation and management visit, 30 minutes | 85 | $27,606 | $58 |
| Therapy using electrical currents | 47 | $25,503 | $98 |
| Psychiatric diagnostic evaluation with medical services | 55 | $9,351 | $125 |
| Return visit (30+ min) | 15 | $5,161 | $72 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $2,685 | $65 |
2019: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 81 | $44,223 | $92 |
| Psychotherapy with evaluation and management visit, 30 minutes | 71 | $20,992 | $56 |
| Therapy using electrical currents | 33 | $19,073 | $95 |
| Psychotherapy with evaluation and management visit, 45 minutes | 41 | $16,681 | $72 |
| Return visit (30+ min) | 19 | $7,910 | $93 |
| Return visit (30+ min) | 13 | $7,673 | $70 |
| Psychiatric diagnostic evaluation with medical services | 47 | $7,263 | $119 |
| Psychotherapy with evaluation and management visit, 45 minutes | 13 | $3,389 | $75 |
| Psychotherapy with evaluation and management visit, 30 minutes | 15 | $2,233 | $57 |
2018: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $29,515 | $86 |
| Therapy using electrical currents | 38 | $19,129 | $90 |
| Psychotherapy with evaluation and management visit, 30 minutes | 52 | $14,079 | $53 |
| Psychiatric diagnostic evaluation with medical services | 36 | $5,050 | $115 |
| Psychotherapy with evaluation and management visit, 45 minutes | 17 | $4,755 | $66 |
2017: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $24,310 | $86 |
| Psychotherapy with evaluation and management visit, 30 minutes | 58 | $17,787 | $52 |
| Therapy using electrical currents | 36 | $16,190 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $5,416 | $60 |
| Psychiatric diagnostic evaluation with medical services | 30 | $4,148 | $112 |
| Short return visit (20+ min) | 11 | $2,927 | $60 |
| Psychotherapy with evaluation and management visit, 30 minutes | 11 | $2,126 | $51 |
| Psychotherapy with evaluation and management visit, 45 minutes | 13 | $1,866 | $67 |
2016: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 55 | $33,663 | $85 |
| Psychotherapy with evaluation and management visit, 30 minutes | 48 | $22,921 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $15,067 | $60 |
| Therapy using electrical currents | 29 | $8,144 | $89 |
| Psychiatric diagnostic evaluation with medical services | 25 | $3,775 | $114 |
2015: 5 services
| Psychotherapy with evaluation and management visit, 30 minutes | 57 | $16,498 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $13,646 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $12,729 | $88 |
| Therapy using electrical currents | 32 | $7,231 | $93 |
| Psychiatric diagnostic evaluation with medical services | 24 | $3,796 | $115 |
2014: 5 services
| Psychotherapy with evaluation and management visit, 30 minutes | 39 | $14,172 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $11,450 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $8,393 | $89 |
| Psychiatric diagnostic evaluation with medical services | 23 | $2,829 | $109 |
| Therapy using electrical currents | 15 | $2,461 | $95 |
2013: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,905 | $61 |
| Psychotherapy with evaluation and management visit, 30 minutes | 29 | $1,637 | $35 |
Drugs they prescribed that Part D paid
$92,382
Pharmacies billed $92,382 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
872 generic and fewer than 11 brand-name prescriptions · $92,382 in drug cost · 64 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Emsam | 15 | $29,570 | $1,971 |
| Lurasidone | 13 | $7,453 | $573 |
| Lisdexamfetamine Dimesylate | 21 | $5,808 | $277 |
| Chlorpromazine | 16 | $2,624 | $164 |
| Asenapine Maleate | 11 | $1,230 | $112 |
See all 34 drugs
| Emsam | 15 | $29,570 | $1,971 |
| Lurasidone | 13 | $7,453 | $573 |
| Lisdexamfetamine Dimesylate | 21 | $5,808 | $277 |
| Chlorpromazine | 16 | $2,624 | $164 |
| Asenapine Maleate | 11 | $1,230 | $112 |
| Quetiapine | 38 | $1,040 | $27 |
| Gabapentin | 27 | $1,036 | $38 |
| Divalproex Sodium Er | 21 | $958 | $46 |
| Olanzapine Odt | 14 | $418 | $30 |
| Divalproex | 21 | $402 | $19 |
| Trazodone | 41 | $393 | $10 |
| Bupropion Hcl Sr | 36 | $331 | $9 |
| Olanzapine | 25 | $325 | $13 |
| Mirtazapine | 24 | $320 | $13 |
| Aripiprazole | 24 | $293 | $12 |
| Naltrexone | 12 | $264 | $22 |
| Venlafaxine Hcl Er | 11 | $257 | $23 |
| Hydroxyzine | 16 | $249 | $16 |
| Bupropion Xl | 21 | $220 | $10 |
| Benztropine Mesylate | 22 | $202 | $9 |
| Quetiapine Fumarate Er | 11 | $198 | $18 |
| Temazepam | 12 | $177 | $15 |
| Paroxetine | 13 | $161 | $12 |
| Clonazepam | 32 | $139 | $4 |
| Propranolol | 20 | $137 | $7 |
| Risperidone | 22 | $125 | $6 |
| Lithium Carbonate Er | 20 | $110 | $6 |
| Lorazepam | 20 | $99 | $5 |
| Omeprazole | 11 | $98 | $9 |
| Topiramate | 15 | $76 | $5 |
| Diazepam | 14 | $61 | $4 |
| Amlodipine Besylate | 14 | $29 | $2 |
| Losartan | 11 | $22 | $2 |
| Clonidine | 16 | $14 | $1 |
Year by year
| 2024 | 923 | 67 | None | None | $92,382 |
| 2023 | 541 | 70 | None | None | $54,131 |
| 2022 | 715 | 78 | None | None | $91,355 |
| 2021 | 535 | 60 | None | None | $41,834 |
| 2020 | 905 | 78 | None | None | $77,235 |
| 2019 | 1,143 | 76 | None | None | $110,386 |
| 2018 | 1,139 | 62 | None | 13% | $102,720 |
| 2017 | 825 | 52 | None | 12% | $88,920 |
| 2016 | 697 | 73 | 2% (13) | None | $44,880 |
| 2015 | 369 | 44 | 4% (14) | None | $17,682 |
| 2014 | 168 | 28 | None | None | $23,522 |
| 2013 | 245 | 25 | 0% (0) | 17% | $20,576 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Divalproex Sodium Er | 15 | $1,673 | $112 |
| Olanzapine | 25 | $1,290 | $52 |
| Olanzapine Odt | 23 | $1,166 | $51 |
| Trazodone | 36 | $457 | $13 |
| Prazosin | 16 | $418 | $26 |
| Quetiapine | 26 | $374 | $14 |
| Mirtazapine | 29 | $345 | $12 |
| Gabapentin | 15 | $332 | $22 |
| Benztropine Mesylate | 13 | $328 | $25 |
| Bupropion Xl | 11 | $281 | $26 |
| Risperidone | 17 | $272 | $16 |
| Lorazepam | 18 | $241 | $13 |
| Duloxetine | 11 | $211 | $19 |
| Hydroxyzine | 11 | $166 | $15 |
2022: 20 drugs
| Latuda | 17 | $27,247 | $1,603 |
| Olanzapine | 51 | $2,937 | $58 |
| Divalproex Sodium Er | 18 | $2,403 | $134 |
| Aripiprazole | 18 | $1,568 | $87 |
| Quetiapine | 15 | $812 | $54 |
| Bupropion Xl | 24 | $707 | $29 |
| Duloxetine | 26 | $564 | $22 |
| Mirtazapine | 36 | $529 | $15 |
| Trazodone | 42 | $487 | $12 |
| Oxcarbazepine | 11 | $480 | $44 |
| Propranolol Hcl Er | 12 | $462 | $39 |
| Venlafaxine Hcl Er | 17 | $300 | $18 |
| Gabapentin | 11 | $293 | $27 |
| Hydroxyzine | 18 | $281 | $16 |
| Lorazepam | 26 | $199 | $8 |
| Sertraline | 16 | $131 | $8 |
| Risperidone | 12 | $105 | $9 |
| Atorvastatin | 17 | $90 | $5 |
| Clonazepam | 24 | $87 | $4 |
| Amlodipine Besylate | 12 | $46 | $4 |
2021: 14 drugs
| Olanzapine | 32 | $947 | $30 |
| Aripiprazole | 20 | $703 | $35 |
| Bupropion Xl | 16 | $647 | $40 |
| Propranolol Hcl Er | 15 | $589 | $39 |
| Quetiapine | 17 | $430 | $25 |
| Duloxetine | 22 | $429 | $19 |
| Trazodone | 44 | $348 | $8 |
| Mirtazapine | 18 | $262 | $15 |
| Levothyroxine | 17 | $159 | $9 |
| Clonazepam | 20 | $123 | $6 |
| Atorvastatin | 11 | $88 | $8 |
| Lorazepam | 11 | $80 | $7 |
| Lamotrigine | 11 | $73 | $7 |
| Amlodipine Besylate | 12 | $50 | $4 |
2020: 26 drugs
| Bupropion Xl | 29 | $1,905 | $66 |
| Aripiprazole | 17 | $1,838 | $108 |
| Trazodone | 68 | $1,584 | $23 |
| Clozapine | 18 | $1,439 | $80 |
| Prazosin | 11 | $873 | $79 |
| Fluvoxamine Maleate | 13 | $828 | $64 |
| Olanzapine | 43 | $812 | $19 |
| Duloxetine | 41 | $730 | $18 |
| Propranolol Hcl Er | 14 | $714 | $51 |
| Propranolol | 31 | $564 | $18 |
| Mirtazapine | 32 | $484 | $15 |
| Risperidone | 45 | $424 | $9 |
| Hydroxyzine | 23 | $369 | $16 |
| Levothyroxine | 32 | $336 | $10 |
| Lorazepam | 32 | $319 | $10 |
| Lithium Carbonate Er | 17 | $271 | $16 |
| Topiramate | 15 | $254 | $17 |
| Clonazepam | 33 | $219 | $7 |
| Gabapentin | 20 | $217 | $11 |
| Lamotrigine | 16 | $216 | $14 |
| Quetiapine | 15 | $199 | $13 |
| Buspirone | 11 | $179 | $16 |
| Lithium Carbonate | 11 | $89 | $8 |
| Atorvastatin | 15 | $89 | $6 |
| Pantoprazole | 17 | $76 | $4 |
| Sertraline | 17 | $73 | $4 |
2019: 37 drugs
| Latuda | 17 | $21,455 | $1,262 |
| Emsam | 11 | $17,918 | $1,629 |
| Saphris | 17 | $12,886 | $758 |
| Amitiza | 12 | $4,492 | $374 |
| Vyvanse | 13 | $4,113 | $316 |
| Aripiprazole | 42 | $3,321 | $79 |
| Bupropion Xl | 66 | $3,277 | $50 |
| Duloxetine | 42 | $1,916 | $46 |
| Olanzapine Odt | 20 | $1,728 | $86 |
| Prazosin | 16 | $1,513 | $95 |
| Trazodone | 54 | $1,359 | $25 |
| Clozapine | 13 | $1,307 | $101 |
| Ziprasidone | 14 | $1,089 | $78 |
| Divalproex Sodium Er | 14 | $1,075 | $77 |
| Quetiapine | 33 | $868 | $26 |
| Olanzapine | 50 | $730 | $15 |
| Levothyroxine | 28 | $569 | $20 |
| Propranolol | 26 | $522 | $20 |
| Mirtazapine | 35 | $514 | $15 |
| Hydroxyzine | 26 | $459 | $18 |
| Clonazepam | 64 | $415 | $6 |
| Lamotrigine | 41 | $401 | $10 |
| Venlafaxine Hcl Er | 13 | $296 | $23 |
| Gabapentin | 26 | $296 | $11 |
| Divalproex | 11 | $283 | $26 |
| Buspirone | 14 | $267 | $19 |
| Lithium Carbonate Er | 12 | $221 | $18 |
| Lorazepam | 23 | $206 | $9 |
| Pantoprazole | 15 | $192 | $13 |
| Benztropine Mesylate | 19 | $191 | $10 |
| Atorvastatin | 12 | $170 | $14 |
| Paroxetine | 15 | $167 | $11 |
| Sertraline | 16 | $159 | $10 |
| Risperidone | 19 | $138 | $7 |
| Metformin | 20 | $125 | $6 |
| Fluoxetine | 11 | $79 | $7 |
| Amlodipine Besylate | 11 | $55 | $5 |
2018: 29 drugs
| Emsam | 13 | $21,176 | $1,629 |
| Latuda | 12 | $12,700 | $1,058 |
| Risperdal Consta | 19 | $9,052 | $476 |
| Tranylcypromine Sulfate | 16 | $7,778 | $486 |
| Aripiprazole | 37 | $4,621 | $125 |
| Bupropion Xl | 55 | $3,576 | $65 |
| Celecoxib | 14 | $3,087 | $220 |
| Methylphenidate Er | 13 | $2,622 | $202 |
| Duloxetine | 47 | $1,894 | $40 |
| Ziprasidone | 29 | $1,415 | $49 |
| Prazosin | 15 | $1,339 | $89 |
| Clonazepam | 65 | $816 | $13 |
| Divalproex Sodium Er | 16 | $779 | $49 |
| Trazodone | 69 | $758 | $11 |
| Rosuvastatin | 11 | $614 | $56 |
| Buspirone | 24 | $578 | $24 |
| Risperidone | 29 | $575 | $20 |
| Propranolol | 29 | $569 | $20 |
| Quetiapine | 39 | $566 | $15 |
| Venlafaxine Hcl Er | 35 | $545 | $16 |
| Mirtazapine | 52 | $516 | $10 |
| Olanzapine | 23 | $507 | $22 |
| Levothyroxine | 29 | $468 | $16 |
| Gabapentin | 25 | $335 | $13 |
| Lithium Carbonate Er | 23 | $291 | $13 |
| Lorazepam | 35 | $284 | $8 |
| Lamotrigine | 33 | $277 | $8 |
| Zolpidem | 14 | $114 | $8 |
| Guanfacine | 11 | $62 | $6 |
2017: 26 drugs
| Latuda | 16 | $20,766 | $1,298 |
| Tranylcypromine Sulfate | 15 | $6,130 | $409 |
| Aripiprazole | 32 | $5,789 | $181 |
| Duloxetine | 39 | $5,219 | $134 |
| Dextroamphetamine-Amphet Er | 13 | $3,090 | $238 |
| Bupropion Xl | 47 | $2,583 | $55 |
| Ziprasidone | 21 | $1,170 | $56 |
| Trazodone | 54 | $980 | $18 |
| Olanzapine | 12 | $961 | $80 |
| Gabapentin | 23 | $408 | $18 |
| Clonazepam | 60 | $396 | $7 |
| Quetiapine | 36 | $353 | $10 |
| Mirtazapine | 31 | $314 | $10 |
| Lamotrigine | 24 | $313 | $13 |
| Venlafaxine Hcl Er | 28 | $307 | $11 |
| Levothyroxine | 24 | $305 | $13 |
| Propranolol | 16 | $297 | $19 |
| Buspirone | 12 | $207 | $17 |
| Liothyronine | 11 | $196 | $18 |
| Lorazepam | 23 | $182 | $8 |
| Risperidone | 27 | $136 | $5 |
| Lithium Carbonate | 16 | $104 | $7 |
| Benztropine Mesylate | 13 | $82 | $6 |
| Topiramate | 11 | $75 | $7 |
| Paroxetine | 14 | $63 | $5 |
| Lithium Carbonate Er | 12 | $23 | $2 |
2016: 20 drugs
| Aripiprazole | 22 | $9,192 | $418 |
| Duloxetine | 18 | $4,329 | $240 |
| Bupropion Xl | 28 | $1,238 | $44 |
| Eszopiclone | 11 | $1,167 | $106 |
| Ziprasidone | 19 | $1,040 | $55 |
| Olanzapine | 25 | $541 | $22 |
| Risperidone | 26 | $519 | $20 |
| Quetiapine | 35 | $446 | $13 |
| Venlafaxine Hcl Er | 20 | $417 | $21 |
| Trazodone | 51 | $386 | $8 |
| Mirtazapine | 27 | $345 | $13 |
| Clonazepam | 37 | $314 | $8 |
| Benztropine Mesylate | 14 | $204 | $15 |
| Lamotrigine | 21 | $189 | $9 |
| Gabapentin | 15 | $183 | $12 |
| Liothyronine | 11 | $175 | $16 |
| Lorazepam | 26 | $149 | $6 |
| Fluphenazine | 11 | $126 | $11 |
| Escitalopram | 13 | $88 | $7 |
| Diazepam | 11 | $15 | $1 |
2015: 10 drugs
| Bupropion Xl | 18 | $638 | $35 |
| Quetiapine | 14 | $486 | $35 |
| Gabapentin | 22 | $299 | $14 |
| Venlafaxine Hcl Er | 22 | $276 | $13 |
| Olanzapine | 19 | $250 | $13 |
| Lamotrigine | 17 | $212 | $12 |
| Trazodone | 37 | $189 | $5 |
| Lorazepam | 16 | $111 | $7 |
| Clonazepam | 16 | $105 | $7 |
| Sertraline | 11 | $98 | $9 |
2014: 1 drug
| Abilify | 13 | $10,156 | $781 |
2013: 7 drugs
| Buspirone | 17 | $957 | $56 |
| Bupropion Xl | 13 | $405 | $31 |
| Lamotrigine | 38 | $397 | $10 |
| Risperidone | 11 | $207 | $19 |
| Clonazepam | 16 | $74 | $5 |
| Trazodone | 11 | $68 | $6 |
| Lorazepam | 11 | $64 | $6 |
Professional record
- NPI
- 1255659355
- Licence
- CA A117757California A117757: Current · expires 2027-06-30
- Trained
- University of Texas Southwestern Medical School at Dallas, 2010 · 16 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 401 Parnassus Ave, Box 0984, San Francisco, CA, 94143
- NPI first listed
- 2010-05-13
- NPI last updated
- 2013-03-07
This is when the NPI record was last certified, not a medical board exam.